Clinical Studies
At MolnuFIP™, we are dedicated to providing evidence-based treatments for feline infectious peritonitis (FIP) and feline calicivirus (FCV). This page highlights the extensive clinical research and studies that support the efficacy and safety of our therapeutic solutions against these serious viral infections.
Read the full Study: https://new.vetscripts.co.za/wp-content/uploads/2025/10/28-Molnupiravir–Doxycycline–Meloxicam-Paste-for-Feline-Gingivostomatitis.pdf
Feline chronic gingivostomatitis (FCGS) and juvenile gingivitis are debilitating oral inflammatory syndromes causing severe pain, weight loss, and reduced quality of life. Standard treatment with full-mouth dental extractions achieves remission in only ~60–70% of cases, leaving many cats refractory. A combination paste incorporating an antiviral (molnupiravir), antibiotic (doxycycline), and anti-inflammatory (meloxicam) offers a novel multimodal therapeutic strategy targeting the multifactorial nature of disease.
Clinical trial of molnupiravir with or without an oral immune stimulant as a first-line treatment of feline infectious peritonitis
Read the full Study: https://pmc.ncbi.nlm.nih.gov/articles/PMC12858776/
Alternative treatments for cats with FIP and natural or acquired resistance to GS-441524
The long history of Beta-d-N4-hydroxycytidine and its modern application to treatment of Covid-19 in people and FIP in cats.
Feline Infectious Peritonitis: European Advisory Board on Cat Diseases Guidelines
Read the full Study: https://pmc.ncbi.nlm.nih.gov/articles/PMC10535984/
Efficacy against Feline Infectious Peritonitis Virus with Pharmacokinetic Analyses of GS-441524, Remdesivir, and Molnupiravir in Cats
Read the full Study: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697187/
Unlicensed Molnupiravir is an Effective Rescue Treatment Following Failure of Unlicensed GS-441524-like Therapy for Cats with Suspected Feline Infectious Peritonitis
Read the full Study: https://pmc.ncbi.nlm.nih.gov/articles/PMC9612227/